Brief: United Laboratories International Says Unit Received Notice Of Approval Of Clinical Trial
26/10/2022 16:06
Oct 26 (Reuters) - United Laboratories International
3933.HK :
* UNIT RECEIVED NOTICE OF APPROVAL OF CLINICAL TRIAL ISSUED
BY
CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION
* APPROVAL BY NMPA REGARDING SEMAGLUTIDE INJECTION APPLIED
BY
UNITED BIO-TECHNOLOGY
Further company coverage: 3933.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million